Loading data
SGINYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 7.48 bn USD | 4.93 bn USD | 4.93 bn USD | 4.92 bn USD | 4.93 bn USD |
| Cost of revenue | 4.29 bn USD | 2.9 bn USD | 2.94 bn USD | 2.87 bn USD | 2.77 bn USD |
| Gross profit | 3.18 bn USD | 2.03 bn USD | 1.99 bn USD | 2.05 bn USD | 2.16 bn USD |
| Research and development expense | 32.9 m USD | 30.8 m USD | 30.6 m USD | 29.2 m USD | 27.3 m USD |
| Operating profit | 754.9 m USD | 634.2 m USD | 607.2 m USD | 680.6 m USD | 912.3 m USD |
| Interest expense | — | — | 129.9 m USD | 103 m USD | 66.3 m USD |
| Profit before tax | 481 m USD | 504.3 m USD | 474.1 m USD | 577.2 m USD | — |
| Income tax expense | 95.7 m USD | 118.6 m USD | 103.4 m USD | 119 m USD | 198.3 m USD |
| Net income (reported basis) | 384.1 m USD | 384.3 m USD | 368.1 m USD | 455.7 m USD | 624.5 m USD |
| Basic earnings per share | 1.86 USD/share | 2.21 USD/share | 2.14 USD/share | 2.61 USD/share | 3.17 USD/share |
| Diluted earnings per share | 1.84 USD/share | 2.16 USD/share | 2.08 USD/share | 2.53 USD/share | 3.06 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.